exclusive rights
-
Biologics
BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease
— Intellectual Property Provides a Cell-Based Therapeutic Platform Designed to Target All Avascular Zones— MELVILLE, N.Y., Dec. 05, 2022 (GLOBE NEWSWIRE)…
Read More » -
Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
LITTLETON, Mass., Dec. 7, 2010 /PRNewswire/ — Audax Medical, Inc. (www.audaxmed.com), a privately-held medical device company specializing in the development of osteobiologics,…
Read More »